[Brain metastasis of prostatic cancer: regression under hormonal treatment].
Central nervous system metastases from prostate cancer are exceptional secondary sites, reported in less than 4% of postmortem cases. The authors describe an unusual case of cerebral metastasis from prostate cancer in a 44-year-old man that temporarily regressed during endocrine therapy.
Ameur
A
A
Service d'Urologie, Hôpital Militaire d'Instruction Mohammed V, BP 1018, Rabat, Maroc. ahmed ameur.1@caramail.com
Touiti
D
D
el Mostarchid
B
B
el Alami
M
M
Jira
H
H
Abbar
M
M
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000556:secondary*; D000328:Adult; D000726:Androgen Antagonists / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D017373:Cyproterone Acetate / Q000627:therapeutic use*; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D012074:Remission Induction
D000726:Androgen Antagonists; D017373:Cyproterone Acetate